Tryp Therapeutics announced on Wednesday that it had “submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its planned Phase 2a clinical trial investigating the effects of psilocybin-assisted psychotherapy in the treatment of patients aged 21+ suffering from Irritable Bowel Syndrome (IBS) at Massachusetts General Hospital (MGH).”

The Canadian company said in the announcement that the “planned open label study in collaboration with Harvard Medical School/Massachusetts General Hospital will evaluate the effect of psilocybin-assisted psychotherapy in patients with treatment-resistant IBS who experience chronic abdominal pain and other debilitating gastrointestinal symptoms.” 

“Many of these

Read full article on High Times

A new era kicked off in Amsterdam’s Red Light District on Thursday, with a ban on smoking cannabis on the streets officially taking effect.

The ban is part of a city-wide effort, pushed by Mayor Femke Halsema, to make the famous area more hospitable to its residents and workers.

According to Reuters, signs “were posted in the canal-lined neighbourhood known for its brothels, sex clubs and marijuana cafes, which attract millions of tourists a year, but are a nuisance to residents.”

Those found in violation of the new law will face a €100 (or about $110) fine.

The law was

Read full article on High Times

Colorado Gov. Jared Polis signed a bill into law on May 23 that established a regulatory framework for psychedelic substances. 

SB23-290, also called Natural Medicine Regulation and Legalization, was signed just a few weeks after it was approved in the Senate with House amendments. The bill was sponsored by Sen. Steven Fenberg and Rep. Judy Amabile, and is set to take effect starting on July 1.

The Colorado Times Recorder spoke with Tasia Poinsatte, director of the Healing Advocacy Fund of Colorado, last month about the bill’s potential. “Our state is facing a mental health crisis, and our current system

Read full article on High Times